Alnylam Pharmaceuticals, Inc.
2023 Q2 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 425 | 0.0% | 1,070 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 488 | 0.0% | 1,070 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 349 | 0.0% | 1,070 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 501 | 0.0% | 1,856 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 9,771 | 0.1% | 41,525 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 11,675 | 0.1% | 42,449 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 10,479 | 0.1% | 43,124 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 8,133 | 0.1% | 54,421 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 9,525 | 0.1% | 49,761 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 1,109 | 0.0% | 6,261 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,207 | 0.0% | 6,354 | 6/30/2023 |